SCHEMBL23370704

SCHEMBL23370704

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CC(CCCOC(=O)CCCCO[N+](=O)[O-])C4)ccc3OCC)nc12

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.78
HDAC1 Q13547 3/20 0.62
HDAC6 Q9UBN7 3/20 0.62
HDAC2 Q92769 2/20 0.62
PDE3B Q13370 4/20 0.60
PDE3A Q14432 4/20 0.60
ABCC4 O15439 2/20 0.60
PDE2A O00408 1/20 0.60
ABCC5 O15440 1/20 0.60
PDE6D O43924 1/20 0.60
PDE8A O60658 1/20 0.60
PDE9A O76083 1/20 0.60
ABCB11 O95342 1/20 0.60
CYP3A4 P08684 1/20 0.60
HTR1A P08908 1/20 0.60
PDE6A P16499 1/20 0.60
PDE6G P18545 1/20 0.60
PDE4A P27815 1/20 0.60
ADORA2A P29274 1/20 0.60
ADORA1 P30542 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23370660 0.99 PDE5A (0.77) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL23370703 0.98 PDE5A (0.80) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL24430053 0.93 PDE5A (0.71) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL23370668 0.92 PDE5A (0.68) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL23370669 0.91 PDE5A (0.68) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL23370672 0.91 PDE5A (0.76) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL23370673 0.90 PDE5A (0.77) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL23370711 0.90 PDE5A (0.70) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL21682533 0.89 PDE5A (0.95) PDE5AHDAC1HDAC6HDAC2PDE3B
SCHEMBL29601486 0.89 PDE5A (0.95) PDE5AHDAC1HDAC6HDAC2PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220380376-A1 Nitrogen Oxide-Donating PDE-5 and/or PDE-6 Inhibitor Compounds ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-12-01 US disclosed
EP-4058457-A2 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS Ildong Pharmaceutical Co., Ltd. (KR) 2022-09-21 EP disclosed
US-20220153746-A1 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-05-19 US disclosed
US-20220153746-A1 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-05-19 US disclosed
WO-2022096930-A2 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-05-12 WO disclosed
WO-2021094830-A2 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS ILDONG PHARMACEUTICAL CO., LTD. (KR) 2021-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380376-A1 Nitrogen Oxide-Donating PDE-5 and/or PDE-6 Inhibitor Compounds PDE6G, PRKG1, PRKG2 PDE5A 4/4885HDAC1 2200/4885HDAC6 2330/4885
US-20220153746-A1 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF PDE6G, PRKG1, PDE6D PDE5A 4/4885HDAC1 2418/4885HDAC6 2173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.